Specifically, we demonstrate that RelB promotes glioma invasion in the absence of RelA, and that TWEAK preferentially regulates noncanonical NF-κB signaling in glioma through a novel, signal-specific induction of NIK expression. Here, TNFSF12 is linked to central nervous system cancer.